DV
Dividend Vision

BIOCQ Stock — Biocept Inc.

Biocept Inc. (BIOCQ)

Updated November 11, 2026.

BIOCQ is a stock. Total return is 100.0% over the past 1.2 years, 80.9 points ahead of SPY at 19.1%.

Biocept, Inc. was a molecular oncology diagnostics company that developed blood and cerebrospinal fluid tests to identify rare tumor cells and detect cancer-related genetic changes, helping physicians select targeted therapies and monitor treatment resistance across solid tumors and brain cancers. The company does not currently distribute to shareholders. Biocept filed for liquidation under Chapter 7 bankruptcy in October 2023.

BIOCQ dividend yield and income

Price as of 2026-11-11.

The payment date is 09/08/2020.

BIOCQ performance versus SPY

Total return is 100.0% over the past 1.2 years, 80.9 points ahead of SPY at 19.1%. Its deepest 1-year drawdown was 95.0%.

WindowTotal returnCAGR
1M0.0%—
3M100.0%—
6M100.0%—
YTD100.0%—
1Y100.0%—
Since 2025-08-27 (first price on file) · 1.2 years100.0%77.60%

BIOCQ key facts

Asset type
Stock
Asset class
Equity
Inception date
02/05/2014
Distribution frequency
None
Last close
$0.0002 (stale; as of 2026-11-11)
Market cap
$525
Average volume
225
Payment date
09/08/2020
Payout ratio
0.0%
EPS
-$167.55

How Dividend Vision calculates returns

Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BIOCQ risks and drawbacks

The deepest 1-year drawdown on record here is 95.0%.

Who may consider BIOCQ — and who may not

It is a weaker fit for investors who need monthly cash flow (BIOCQ does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on BIOCQ

Tagged: Healthcare.

Frequently asked questions

Does BIOCQ pay monthly?

No. BIOCQ does not currently distribute.

When does BIOCQ pay a dividend?

BIOCQ does not currently distribute. The payment date is 09/08/2020.

How has BIOCQ performed?

Total return is 100.0% over the past 1.2 years, 80.9 points ahead of SPY at 19.1%. Its deepest 1-year drawdown was 95.0%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.